ArticleCurrent medical imaging2026
Radiomics-based Machine Learning Models for Classifying Breast Cancer on Dynamic-Contrast Enhanced MRI through Multi-Observer Analysis
Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correlation between myocardial radiomics features at the left atrium-left atrial appendage junction and stroke risk in atrial fibrillation patients: a retrospective case-control study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast cancer remains a significant global health issue, necessitating rapid alternative diagnostic methods to improve survival rates. This study aimed to evaluate observer performance in the manual segmentation of Dynamic Contrast-Enhanced MRI (DCE-MRI) images and to assess the effectiveness of radiomic features and machine learning (ML) in classifying benign and malignant breast cancer.
methodsBreast lesions from 155 patients (65 benign, 90 malignant) were manually segmented on DCE-MRI images by four experienced radiologists using 3D Slicer (version 5.6.1). From each lesion, 107 radiomic features, including shape, first-order, and texture features, were extracted, yielding a high-dimensional dataset. All features were normalized using Z-score scaling. Feature selection was performed using LASSO regression with fivefold cross-validation. The dataset was divided into training and testing sets in a 70:30 ratio, and model performance was evaluated using five-fold cross-validation. The top 20 radiomic features were selected based on intraclass correlation coefficient (ICC) analysis to ensure feature stability. Nine machine learning models, CatBoost, Random Forest, XGBoost, AdaBoost, Naïve Bayes, Logistic Regression, k-NN, SVC, and MLP were employed for classifications. Hyperparameter tuning was applied to optimize model performance, and SHapley Additive exPlanations (SHAP) were used to identify key predictive features.
resultsICC values ranged from 0.941 to 0.992 (95% CI), demonstrating excellent reliability across all radiomic feature categories. CatBoost outperformed the others with an AUC of 0.937 (95%CI:0.852-0.993) with a sensitivity of 0.889 and a specificity of 0.909 in the internal test set. Other models, such as Random Forest (AUC:0.881, 95%CI:0.758-0.972) and Naïve Bayes (AUC:0.843,95%CI:0.707-0.949), performed well but were less effective compared to CatBoost. SHAP analysis showed that several radiomic features were significant in distinguishing malignant lesions. DISCUSSION: Ensemble-based models generally outperformed traditional classifiers, such as Logistic Regression and k-NN, possibly because they can capture non-linear relationships in the dataset. SHAP analysis provided insight into model interpretability by identifying key features that contributed most significantly to the classification task.
conclusionThis study demonstrates the potential of integrating radiomic features with ML for breast cancer classification. CatBoost exhibited the highest predictive performance, highlighting its effectiveness in distinguishing malignant from benign lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.